双氯芬酸钠.|15307-79-6|(双氯芬酸钠; GP 45840)-陌孚医药/Medlife

您当前的位置：

双氯芬酸钠. (Synonyms: 双氯芬酸钠; GP 45840)

目录号: PC14176 纯度: ≥98%

CAS No. :15307-79-6

商品编号	规格	价格	会员价	是否有货	数量
PC14176-5g	5g	¥372.40	请登录
PC14176-10mM (in 1mL DMSO)	10mM (in 1mL DMSO)	¥490.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	双氯芬酸钠.
中文别名	双氯芬酸钠;桑螵蛸提取物;阿米雷尔;双氯芬酸钠标准品;醋氯芬酸EP杂质A;双氯芬酸钠(二氯芬酸、2-[(2,6-二氯苯基)氨基]-苯乙酸钠、双氯灭痛、双氯芬酸乙酯、服他灵、双氯胺苯乙酸钠、双氯灭痛钠);Diclofenac Sodium Salt 双氯芬酸钠;二氯芬酸;夫西地酸;高纯双氯芬酸钠;双氯芬酸钠 EP标准品;双氯芬酸钠 USP标准品;双氯芬酸钠（双氯灭痛）;双氯芬酸钠,双氯灭痛;双氯芬酸钠盐标准品;双氯芬酸钠用作消炎镇痛药;双氯灭痛;替卡格雷(替格瑞洛);中文名称双氯芬酸钠;2-[(2,6-二氯苯基)氨基]-苯乙酸钠;二氯苯胺苯乙酸钠;服他灵;双氯胺苯乙酸钠;双氯芬酸乙酯;双氯酚酸钠;双氯灭痛钠;药用双氯芬酸钠原料药生产厂家
英文名称	Diclofenac sodium
英文别名	diclofenac sodium;Diclofenac sodium salt;2-[(2,6-dichlorophenyl)amino]benzeneacetic acid sodium salt;sodium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate;2-(2,6-DICHLOROANILINO)PHENYLACETIC ACID SODIUM SALT;Diclofenac (sodium salt);DICLOFENAC SODIUM SALT USP;2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid s;BENFOFEN;Diacron;ECOFENAC;kriplex;KROPLEX;Naclof;Sodium 2-(2,6-Dichloroanilino)phenylacetate;VALETAN;Voldal;药用双氯芬酸钠原料药生产厂家;Sodium diclofenac;Solaraze;Anthraxiton;Prophenatin;Orthophen;Neriodin;Delphimix;Tsudohmin;Batafil;Ortofen;Feloran;Dichronic;Delimon;Vonafec;Voltarene;Allvoran;Vurdon;Urigon;Blesin;Diclophenac sodium;Voltaren ophthalmic;Diclofenac (Sodium);Voltaren-XR;GP 45840;C14H10Cl2NNaO2;Assaren;Dyloject;Olfen;Sodium (o-(2,6-dichloroanilino)phenyl)acetate;Ba 47210;sodium {2-[(2,6-dichlorophenyl)amin
Cas No.	15307-79-6
分子式	C₁₄H₁₀Cl₂NNaO₂
分子量	318.13
包装储存	4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

生物活性

Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC₅₀s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade.

性状

Solid

IC50 & Target[1][2]

Human COX-2

1.3 nM (IC₅₀, in CHO cells)

Human COX-1

4 nM (IC₅₀, in CHO cells)

Ovine COX-2

0.84 μM (IC₅₀)

Ovine COX-1

5.1 μM (IC₅₀)

体外研究(In Vitro)

Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC₅₀ of 7±3 nM.
Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.
Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line:	Neural stem cells (NSCs)
Concentration:	1, 3, 10, 30, 60 μM
Incubation Time:	1 day
Result:	Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM.

Western Blot Analysis

Cell Line:	Neural stem cells (NSCs)
Concentration:	10, 30 or 60 μM
Incubation Time:	6 hours
Result:	The activation of caspase-3 was increased in a concentration-dependent manner.

体内研究(In Vivo)

Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.
Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male Sprague-Dawley rats (150±200 g)
Dosage:	3 mg/kg
Administration:	Oral administration, b.i.d., for 5 days
Result:	Resulted in a significant increase in faecal Cr excretion.

Animal Model:	Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model
Dosage:	10 mg/kg
Administration:	Administered via oral route just prior to induction of inflammation
Result:	Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h).

运输条件

Room temperature or refrigerated transportation.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial

参考文献

[1]. Riendeau D, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121(1):105-17. [Information]

[2]. Labib MB, et al. Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. Bioorg Chem. 2018 Oct;80:70-80. [Information]

[3]. Chiho Kudo, et al. Diclofenac Inhibits Proliferation and Differentiation of Neural Stem Cells. Biochem Pharmacol. 2003 Jul 15;66(2):289-95. [Information]

溶解度数据

体外研究:

H₂O : 10 mg/mL (31.43 mM; ultrasonic and warming and heat to 60°C)

配制储备溶液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	3.1434 mL	15.7168 mL	31.4337 mL
5 mM	0.6287 mL	3.1434 mL	6.2867 mL
10 mM	0.3143 mL	1.5717 mL	3.1434 mL

产品不同，其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液；配成溶液后，建议分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，建议在 6 个月内使用，-20°C 储存时，建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

1.

建议依照次序添加每种溶剂： PBS
Solubility: 4.55 mg/mL (14.30 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation